BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22644295)

  • 21. TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.
    Safina A; Sotomayor P; Limoge M; Morrison C; Bakin AV
    Mol Cancer Res; 2011 Aug; 9(8):1042-53. PubMed ID: 21700681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
    Tai KF; Wang CH
    Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMARCAD1 knockdown uncovers its role in breast cancer cell migration, invasion, and metastasis.
    Al Kubaisy E; Arafat K; De Wever O; Hassan AH; Attoub S
    Expert Opin Ther Targets; 2016 Sep; 20(9):1035-43. PubMed ID: 27232533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.
    Chen Q; Manning CD; Millar H; McCabe FL; Ferrante C; Sharp C; Shahied-Arruda L; Doshi P; Nakada MT; Anderson GM
    Clin Exp Metastasis; 2008; 25(2):139-48. PubMed ID: 18064530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice.
    Rose DP; Connolly JM; Rayburn J; Coleman M
    J Natl Cancer Inst; 1995 Apr; 87(8):587-92. PubMed ID: 7752256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
    Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
    Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
    Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
    Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
    Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
    Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of TAK1 expression in thyroid cancer.
    Lin P; Niu W; Peng C; Zhang Z; Niu J
    Int J Clin Exp Pathol; 2015; 8(11):14449-56. PubMed ID: 26823762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
    Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
    Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro.
    Rose DP; Connolly JM; Liu XH
    Nutr Cancer; 1995; 24(1):33-45. PubMed ID: 7491296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
    Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
    Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
    Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
    J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor.
    Bandyopadhyay A; Agyin JK; Wang L; Tang Y; Lei X; Story BM; Cornell JE; Pollock BH; Mundy GR; Sun LZ
    Cancer Res; 2006 Jul; 66(13):6714-21. PubMed ID: 16818646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.